• Achieve Life Sciences will hold its annual shareholder meeting virtually on July 2, 2026.
• Shareholders will vote on electing nine directors to a one-year term.
• The meeting will also seek approval to double authorized common shares to 300,000,000 from 150,000,000.
• Other items include ratifying PricewaterhouseCoopers as auditor for 2026 and an advisory vote on executive pay.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-248338), on May 29, 2026, and is solely responsible for the information contained therein.